Maxygen Announces Second Quarter 2009 Earnings Release Date

REDWOOD CITY, Calif.--Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company focused on the development of improved protein drugs, announced that it will release its second quarter 2009 financial results on Thursday, August 6, 2009 at approximately 4:00 p.m. ET (1:00 p.m. PT). The earnings release will be available online at www.maxygen.com and will be filed with the Securities and Exchange Commission. Maxygen will not host a conference call in connection with its second quarter results.

About Maxygen

Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs through both internal development and external collaborations and other arrangements. Maxygen uses its proprietary DNA shuffling technology and extensive protein modification expertise to pursue the creation of biosuperior proteins. www.maxygen.com

BiomedReports is not paid or compensated to report news and developments about publicly traded companies. Full disclosure can be read in the About Us Section

---

Add this page to your favorite Social Bookmarking websites